Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2021

Open Access 01-12-2021 | Fluconazole | Research article

Synergistic antifungal evaluation of over-the-counter antifungal creams with turmeric essential oil or Aloe vera gel against pathogenic fungi

Authors: Clement Olusola Ogidi, Ayokunbi Elizabeth Ojo, Oluwatayo Benjamin Ajayi-Moses, Oluwatoyin Modupe Aladejana, Oluwakemi Abike Thonda, Bamidele Juliet Akinyele

Published in: BMC Complementary Medicine and Therapies | Issue 1/2021

Login to get access

Abstract

Background

The frequent incidence of fungal infection and widespread of antibiotic resistance are emergent concerns in public health. Hence, there is a need to harness the potential of natural bioactive compounds from plant towards treatment of fungal infection. Combination effect of antibiotic creams with natural products from plants is prospective strategy to produce new antifungal agent. This study therefore, revealed antifungal effect of combined Antifungal Creams (AFCs) with Turmeric Essential Oil (TEO) or Aloe vera Gel (AVG).

Methods

Phytochemicals and bioactive compounds in TEO and AVG were revealed using GC-MS. Bioactive compounds in plant extracts were compared to known compounds in database library of National Institute of Standards and Technology (U.S.). Antifungal activity and synergistic effect of AFCs with TEO or AVG were carried out using agar well diffusion method.

Results

Phenol, flavonoids, saponins, alkaloids, steroids, terpenoids and cardiac glycosides were present in TEO and AVG. GCMS revealed thirty-six (36) and eighteen (18) bioactive compounds in TEO and AVG, respectively. AFCs displayed zones of inhibition with values ranged from 5.0 to 14.3 mm, TEO was 5.0 to 11.0 mm and AVG was 8.0 to 11.7 mm against tested fungi. Minimum Inhibitory Concentration (MIC) by AFCs, TEO and AVG ranged from 1.25 to 10.0 mg/ml. Combinatory effects of AFCs with TEO or AVG revealed synergistic and indifferent properties.

Conclusion

Development of novel products using bioactive ingredients from plants with commercially available AFCs will serve as potential alternative therapy to cure dermatological infections with no side effects.
Literature
1.
go back to reference Warnock DW. Fungal diseases: an evolving public health challenge. J Med Mycol. 2006;44(8):697–705.CrossRef Warnock DW. Fungal diseases: an evolving public health challenge. J Med Mycol. 2006;44(8):697–705.CrossRef
3.
go back to reference Homei A, Worboys M. Candida: a disease of antibiotics. In: Fungal disease in Britain and the United States 1850–2000. Science, Technology and Medicine in Modern History. London: Palgrave Macmillan; 2013. Homei A, Worboys M. Candida: a disease of antibiotics. In: Fungal disease in Britain and the United States 1850–2000. Science, Technology and Medicine in Modern History. London: Palgrave Macmillan; 2013.
4.
go back to reference Arif T, Bhosale JD, Kumar N, Mandal TK, Bendre RS, Lavekar GS, Dabur R. Natural products – antifungal agents derived from plants. J Asian Nat Prod Res. 2019;11(7):621–38.CrossRef Arif T, Bhosale JD, Kumar N, Mandal TK, Bendre RS, Lavekar GS, Dabur R. Natural products – antifungal agents derived from plants. J Asian Nat Prod Res. 2019;11(7):621–38.CrossRef
5.
go back to reference Scorzoni L, de Paula e Silva ACA, Marcos CM, Assato PA, de Melo WCM, de Oliveira HC, Costa-Orlandi CB, Mendes-Giannini MJS, Fusco-Almeida AM. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol. 2017;8:36.PubMedPubMedCentralCrossRef Scorzoni L, de Paula e Silva ACA, Marcos CM, Assato PA, de Melo WCM, de Oliveira HC, Costa-Orlandi CB, Mendes-Giannini MJS, Fusco-Almeida AM. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol. 2017;8:36.PubMedPubMedCentralCrossRef
6.
go back to reference Kumar L, Verma S, Bhardwaj A, Vaidya S, Vaidya B. Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artif Cells Nanomed Biotechnol. 2014;42(1):32–46.PubMedCrossRef Kumar L, Verma S, Bhardwaj A, Vaidya S, Vaidya B. Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artif Cells Nanomed Biotechnol. 2014;42(1):32–46.PubMedCrossRef
7.
go back to reference Sousa F, Ferreira D, Reis S, Costa P. Current insights on antifungal therapy: novel nanotechnology approaches for drug delivery systems and new drugs from natural sources. Pharmaceuticals (Basel). 2020;13:248–77.CrossRef Sousa F, Ferreira D, Reis S, Costa P. Current insights on antifungal therapy: novel nanotechnology approaches for drug delivery systems and new drugs from natural sources. Pharmaceuticals (Basel). 2020;13:248–77.CrossRef
8.
go back to reference Spitzer M, Robbins N, Wright GD. Combinatorial strategies for combating invasive fungal infections. Virulence. 2017;8(2):169–85.PubMedCrossRef Spitzer M, Robbins N, Wright GD. Combinatorial strategies for combating invasive fungal infections. Virulence. 2017;8(2):169–85.PubMedCrossRef
9.
go back to reference Vengurlekar S, Sharma R, Trivedi P. Efficacy of some natural compounds as antifungal agents. Pharm Rev. 2012;6(12):91–9. Vengurlekar S, Sharma R, Trivedi P. Efficacy of some natural compounds as antifungal agents. Pharm Rev. 2012;6(12):91–9.
12.
13.
go back to reference Singh R, Dubey AK. Endophytic actinomycetes as emerging source for therapeutic compounds. Indo Global J Pharm Sci. 2015;5:106–16.CrossRef Singh R, Dubey AK. Endophytic actinomycetes as emerging source for therapeutic compounds. Indo Global J Pharm Sci. 2015;5:106–16.CrossRef
16.
go back to reference Bawankar R, Pooja S, Babu S. Bioactive compounds and medicinal properties of Aloe vera L.: an update. J Plant Sci. 2014;3:102–7. Bawankar R, Pooja S, Babu S. Bioactive compounds and medicinal properties of Aloe vera L.: an update. J Plant Sci. 2014;3:102–7.
18.
go back to reference Seema S, Veena U, Bhatt RP. Inhibitory effect of essential oils against Trichosporon ovoides causing piedra hair infection. Braz J Microbiol. 2012;12:1347–54. Seema S, Veena U, Bhatt RP. Inhibitory effect of essential oils against Trichosporon ovoides causing piedra hair infection. Braz J Microbiol. 2012;12:1347–54.
19.
go back to reference Sofowora A. Medicinal plants and traditional medicine in Africa. Ibadan: Spectrum Books; 1993. Sofowora A. Medicinal plants and traditional medicine in Africa. Ibadan: Spectrum Books; 1993.
20.
go back to reference Harborne J. Phytochemical methods: a guide to modern techniques of plant analysis. 3rd ed. London: Chapman and Hill; 1998. Harborne J. Phytochemical methods: a guide to modern techniques of plant analysis. 3rd ed. London: Chapman and Hill; 1998.
21.
go back to reference Trease GE, Evans MC. Pharmacognosy. 14th ed. New Delhi: Elsevier; 2005. Trease GE, Evans MC. Pharmacognosy. 14th ed. New Delhi: Elsevier; 2005.
22.
go back to reference Soladoye MO, Chukwuma EC. Quantitative phytochemical profile of the leaves of Cissus populnea Guill. & Perr. (Vitaceae) – an important medicinal plant in central Nigeria. Arch Appl Sci Res. 2012;4(1):200–6. Soladoye MO, Chukwuma EC. Quantitative phytochemical profile of the leaves of Cissus populnea Guill. & Perr. (Vitaceae) – an important medicinal plant in central Nigeria. Arch Appl Sci Res. 2012;4(1):200–6.
23.
go back to reference Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 3rd ed. Wayne: CLSI supplement M38 Clinical and Laboratory Standards Institute 950; 2017. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 3rd ed. Wayne: CLSI supplement M38 Clinical and Laboratory Standards Institute 950; 2017.
24.
go back to reference Clinical and Laboratory Standards Institute (CLSI). Performance standards for antifungal susceptibility testing of of filamentous fungi. 1st ed. Wayne: CLSI supplement M61 Clinical and Laboratory Standards Institute 950; 2017. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antifungal susceptibility testing of of filamentous fungi. 1st ed. Wayne: CLSI supplement M61 Clinical and Laboratory Standards Institute 950; 2017.
26.
go back to reference Chen X, Ren B, Chen M, Liu MX, Ren W, Wang QX, Zhang LX, Yan GY. ASDCD: antifungal synergistic drug combination database. PLoS One. 2014;9(1):86499.CrossRef Chen X, Ren B, Chen M, Liu MX, Ren W, Wang QX, Zhang LX, Yan GY. ASDCD: antifungal synergistic drug combination database. PLoS One. 2014;9(1):86499.CrossRef
27.
go back to reference Lam P, Stanton HLK, Kenneth KHL, Lam KH, Desmond KPH, Wong WY, Bian Z, Gambari R, Chung HC. Sensitization of Candida albicans to terbinafine by berberine and berberrubine. Biomed Rep. 2016;4(4):449–52.PubMedPubMedCentralCrossRef Lam P, Stanton HLK, Kenneth KHL, Lam KH, Desmond KPH, Wong WY, Bian Z, Gambari R, Chung HC. Sensitization of Candida albicans to terbinafine by berberine and berberrubine. Biomed Rep. 2016;4(4):449–52.PubMedPubMedCentralCrossRef
28.
go back to reference Karri VV, Raman SK, Kuppusamy G, Sanapalli BKR, Wadhwani A, Patel V, Malayandi R. In vitro antifungal activity of a novel allylamine antifungal nanoemulsion gel. J Nanosci Curr Res. 2018;3(1):1–5. Karri VV, Raman SK, Kuppusamy G, Sanapalli BKR, Wadhwani A, Patel V, Malayandi R. In vitro antifungal activity of a novel allylamine antifungal nanoemulsion gel. J Nanosci Curr Res. 2018;3(1):1–5.
29.
go back to reference Babu PR, Pravin AJS, Deshmukh G, Dhoot D, Samant A, Kotak B. Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis. Indian J Dermatol. 2017;62(4):395–9.PubMedPubMedCentralCrossRef Babu PR, Pravin AJS, Deshmukh G, Dhoot D, Samant A, Kotak B. Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis. Indian J Dermatol. 2017;62(4):395–9.PubMedPubMedCentralCrossRef
30.
go back to reference Shivamurthy RP, Reddy SG, Kallappa R, Somashekar SA, Patil D, Patil UN. Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of Tinea corporis- an observational study. J Clin Diagn Res. 2014;8(9):9–12. Shivamurthy RP, Reddy SG, Kallappa R, Somashekar SA, Patil D, Patil UN. Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of Tinea corporis- an observational study. J Clin Diagn Res. 2014;8(9):9–12.
31.
go back to reference Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006;50(6):2009–15.PubMedPubMedCentralCrossRef Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006;50(6):2009–15.PubMedPubMedCentralCrossRef
32.
go back to reference Vandeputte P, Ferrari S, Coste AT. Antifungal resistance and new strategies to control fungal infections. Intern J Microbiol. 2012;ID713687:1–26. Vandeputte P, Ferrari S, Coste AT. Antifungal resistance and new strategies to control fungal infections. Intern J Microbiol. 2012;ID713687:1–26.
33.
go back to reference Saini A, Singh B, Suttee A, Verma S, Garg LK, Thakur S. A review on phytoconstituents: the potent synergistic approach in antimicrobial formulations. J Pharm Res. 2018;12(2):151–9. Saini A, Singh B, Suttee A, Verma S, Garg LK, Thakur S. A review on phytoconstituents: the potent synergistic approach in antimicrobial formulations. J Pharm Res. 2018;12(2):151–9.
34.
go back to reference Sawant RS, Godghate AG. Qualitative phytochemical screening of rhizomes of Curcuma longa Linn. Intern J Sci Environ Technol. 2013;2(4):634–41. Sawant RS, Godghate AG. Qualitative phytochemical screening of rhizomes of Curcuma longa Linn. Intern J Sci Environ Technol. 2013;2(4):634–41.
35.
go back to reference Bawankar R, Deepti VC, Singh P, Subashkumar R, Vivekanandhan G, Babu S. Evaluation of bioactive potential of an Aloe vera sterol extract. Phytother Res. 2013;27(6):864–8.PubMedCrossRef Bawankar R, Deepti VC, Singh P, Subashkumar R, Vivekanandhan G, Babu S. Evaluation of bioactive potential of an Aloe vera sterol extract. Phytother Res. 2013;27(6):864–8.PubMedCrossRef
36.
go back to reference Nurkenov OA, Satpaeva B, Kulakov IV, Akhmetova SB, Zhaugasheva SK. Synthesis and antimicrobial activity of 0- and p- hydroxybenzoic acid thiosemicarbazides. Russian J Gen Chem. 2012;82(4):668–71.CrossRef Nurkenov OA, Satpaeva B, Kulakov IV, Akhmetova SB, Zhaugasheva SK. Synthesis and antimicrobial activity of 0- and p- hydroxybenzoic acid thiosemicarbazides. Russian J Gen Chem. 2012;82(4):668–71.CrossRef
37.
go back to reference Lawrence R, Tripathi P, Jeyakumar E. Isolation, purification and evaluation of antibacterial agents from Aloe vera. Braz J Microbiol. 2009;40(4):906–15.PubMedPubMedCentralCrossRef Lawrence R, Tripathi P, Jeyakumar E. Isolation, purification and evaluation of antibacterial agents from Aloe vera. Braz J Microbiol. 2009;40(4):906–15.PubMedPubMedCentralCrossRef
38.
go back to reference Nazzaro F, Fratianni F, Coppola R, Feo V. Essential oils and antifungal activity. Pharmaceuticals (Basel). 2017;10(4):86.CrossRef Nazzaro F, Fratianni F, Coppola R, Feo V. Essential oils and antifungal activity. Pharmaceuticals (Basel). 2017;10(4):86.CrossRef
39.
go back to reference Chouhan S, Sharma K, Guleria S. Antimicrobial activity of some essential oils-present status and future perspectives. Medicines. 2017;4(3):58.PubMedCentralCrossRef Chouhan S, Sharma K, Guleria S. Antimicrobial activity of some essential oils-present status and future perspectives. Medicines. 2017;4(3):58.PubMedCentralCrossRef
40.
go back to reference Scalas D, Mandras N, Roana J, Tardugno R, Cuffini AM, Ghisetti V, Benvenuti S, Tullio V. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains. BMC Compl Altern Med. 2018;18(1):143. https://doi.org/10.1186/s12906-018-2219-4.CrossRef Scalas D, Mandras N, Roana J, Tardugno R, Cuffini AM, Ghisetti V, Benvenuti S, Tullio V. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains. BMC Compl Altern Med. 2018;18(1):143. https://​doi.​org/​10.​1186/​s12906-018-2219-4.CrossRef
41.
go back to reference İşcan G, Kirimer N, Demirci F, Demirci B, Noma Y, Başer KH. Biotransformation of (−)-(R)-α-phellandrene: antimicrobial activity of its major metabolite. Chem Biodivers. 2012;9(8):1525–32.PubMedCrossRef İşcan G, Kirimer N, Demirci F, Demirci B, Noma Y, Başer KH. Biotransformation of (−)-(R)-α-phellandrene: antimicrobial activity of its major metabolite. Chem Biodivers. 2012;9(8):1525–32.PubMedCrossRef
42.
go back to reference Mukesi M, Iweriebor BC, Obi LC, Uwodo UU, Moyo SR, Okoh AI. The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women. BMC Complement Altern Med. 2019;19:34.PubMedPubMedCentralCrossRef Mukesi M, Iweriebor BC, Obi LC, Uwodo UU, Moyo SR, Okoh AI. The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women. BMC Complement Altern Med. 2019;19:34.PubMedPubMedCentralCrossRef
43.
go back to reference Zviely M, Hong C. Hydrocarbons: significance in the flavor and fragrance industries. Perfumer Flavorist Chem. 2019;34:1–9. Zviely M, Hong C. Hydrocarbons: significance in the flavor and fragrance industries. Perfumer Flavorist Chem. 2019;34:1–9.
44.
go back to reference Kim JH, Cha JY, Shin TS, Chun SS. Volatile flavor components of blended tea with fermented tea and herbs. Preven Nutr Food Sci. 2018;23(3):245–53.CrossRef Kim JH, Cha JY, Shin TS, Chun SS. Volatile flavor components of blended tea with fermented tea and herbs. Preven Nutr Food Sci. 2018;23(3):245–53.CrossRef
45.
go back to reference Ferreira FD, Mossini SAG, Ferreira FMD, Arrotéia CC, da Costa CL, Nakamura CV, Junior MM. The inhibitory effects of Curcuma longa L. essential oil and Curcumin on Aspergillus flavus link growth and morphology. Sci World J. 2013;ID 343804:1–6. Ferreira FD, Mossini SAG, Ferreira FMD, Arrotéia CC, da Costa CL, Nakamura CV, Junior MM. The inhibitory effects of Curcuma longa L. essential oil and Curcumin on Aspergillus flavus link growth and morphology. Sci World J. 2013;ID 343804:1–6.
47.
go back to reference Rezazadeh F, Moshaverinia M, Motamedifar M, Alyaseri M. Assessment of anti HSV-1 activity of Aloe vera gel extract: an in vitro study. J Dent (Shiraz). 2016;17(1):49–54. Rezazadeh F, Moshaverinia M, Motamedifar M, Alyaseri M. Assessment of anti HSV-1 activity of Aloe vera gel extract: an in vitro study. J Dent (Shiraz). 2016;17(1):49–54.
49.
go back to reference Nidiry ESJ, Ganeshan G, Lokesha AN. Antifungal activity of some extractives and constituents of Aloe vera. Res J Med Plant. 2011;5:196–200.CrossRef Nidiry ESJ, Ganeshan G, Lokesha AN. Antifungal activity of some extractives and constituents of Aloe vera. Res J Med Plant. 2011;5:196–200.CrossRef
50.
go back to reference Khwakhali US and Shrivatava VP. Antifungal activity of Aloe vera extract against pathogenic species of Aspergillus isolated from Kathmandu, Nepal. 6th Advances against Aspergillosis, Madrid, Spain 27, February-1 March, 2014. http://www.AAA2014.org. Khwakhali US and Shrivatava VP. Antifungal activity of Aloe vera extract against pathogenic species of Aspergillus isolated from Kathmandu, Nepal. 6th Advances against Aspergillosis, Madrid, Spain 27, February-1 March, 2014. http://​www.​AAA2014.​org.
51.
go back to reference Al-Snafi AE. The pharmacological importance of Aloe vera- a review. Intern J Phytopharm Res. 2015;6(1):28–33. Al-Snafi AE. The pharmacological importance of Aloe vera- a review. Intern J Phytopharm Res. 2015;6(1):28–33.
52.
go back to reference Saks Y, Barkai-Golan R. Aloe vera activity against plant pathogenic fungi. Postharvest Biol Technol. 1995;6:159–65.CrossRef Saks Y, Barkai-Golan R. Aloe vera activity against plant pathogenic fungi. Postharvest Biol Technol. 1995;6:159–65.CrossRef
53.
go back to reference Yebpella GG, Hammuel C, Adeyemi HMM, Magomya AM, Agbaji AS, Shallangwa GA. Phytochemical screening and a comparative study of antibacterial activity of Aloe vera green rind, gel and leaf pulp extracts. Int Res J Microbiol. 2011;2(10):382–6. Yebpella GG, Hammuel C, Adeyemi HMM, Magomya AM, Agbaji AS, Shallangwa GA. Phytochemical screening and a comparative study of antibacterial activity of Aloe vera green rind, gel and leaf pulp extracts. Int Res J Microbiol. 2011;2(10):382–6.
54.
go back to reference Radha MH, Laxmipriya NP. Evaluation of biological properties and clinical effectiveness of Aloe vera: a systemic review. J Tradit Complement Med. 2015;5:21–6.PubMedCrossRef Radha MH, Laxmipriya NP. Evaluation of biological properties and clinical effectiveness of Aloe vera: a systemic review. J Tradit Complement Med. 2015;5:21–6.PubMedCrossRef
55.
go back to reference Laxminarain M. Traditional phytomedicinal systems, scientific validations and current popularity as nutraceuticals. Intern J Trad Nat Med. 2013;2(1):27–75. Laxminarain M. Traditional phytomedicinal systems, scientific validations and current popularity as nutraceuticals. Intern J Trad Nat Med. 2013;2(1):27–75.
56.
go back to reference Jankasem M, Wuthi-udomlert M, Gritsanapan W. Antidermatophytic properties of Ar-turmerone, turmeric oil, and Curcuma longa preparations. ISRN Dermatol. 2013;1–3:250597. Jankasem M, Wuthi-udomlert M, Gritsanapan W. Antidermatophytic properties of Ar-turmerone, turmeric oil, and Curcuma longa preparations. ISRN Dermatol. 2013;1–3:250597.
57.
go back to reference Shin S, Lim S. Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp. J Appl Microbiol. 2004;97:1289–96.PubMedCrossRef Shin S, Lim S. Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp. J Appl Microbiol. 2004;97:1289–96.PubMedCrossRef
58.
go back to reference El-Ahmady S, El-Shazly M, Milad R. The synergetic efficacy of the combination of amphotericin B and certain essential oils against selected fungal clinical isolates. J Appl Pharm Sci. 2013;3(4):26–30. El-Ahmady S, El-Shazly M, Milad R. The synergetic efficacy of the combination of amphotericin B and certain essential oils against selected fungal clinical isolates. J Appl Pharm Sci. 2013;3(4):26–30.
59.
go back to reference Shin S. Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B. Arch Pharm Res. 2013;26:389.CrossRef Shin S. Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B. Arch Pharm Res. 2013;26:389.CrossRef
60.
go back to reference Duarte A, Ferreira S, Silva F, et al. Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii. Phytomedicine. 2012;19:236–8.PubMedCrossRef Duarte A, Ferreira S, Silva F, et al. Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii. Phytomedicine. 2012;19:236–8.PubMedCrossRef
61.
go back to reference Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? Pharmacogn Rev. 2017;11(22):57–72.PubMedPubMedCentralCrossRef Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? Pharmacogn Rev. 2017;11(22):57–72.PubMedPubMedCentralCrossRef
62.
go back to reference Orchard A, van Vuuren S. Commercial essential oils as potential antimicrobials to treat skin diseases. Evid Based Complement Alternat Med. 2017:ID 4517971 1–92. Orchard A, van Vuuren S. Commercial essential oils as potential antimicrobials to treat skin diseases. Evid Based Complement Alternat Med. 2017:ID 4517971 1–92.
Metadata
Title
Synergistic antifungal evaluation of over-the-counter antifungal creams with turmeric essential oil or Aloe vera gel against pathogenic fungi
Authors
Clement Olusola Ogidi
Ayokunbi Elizabeth Ojo
Oluwatayo Benjamin Ajayi-Moses
Oluwatoyin Modupe Aladejana
Oluwakemi Abike Thonda
Bamidele Juliet Akinyele
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2021
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-021-03205-5

Other articles of this Issue 1/2021

BMC Complementary Medicine and Therapies 1/2021 Go to the issue